Sector Gamma As as of Dec. 31, 2022
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 31 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 11.7 | $51M | 596k | 85.85 | |
| Incyte Corporation (INCY) | 7.6 | $33M | 412k | 80.32 | |
| Cardinal Health (CAH) | 6.2 | $27M | 354k | 76.87 | |
| Bristol Myers Squibb (BMY) | 6.2 | $27M | 378k | 71.95 | |
| Anthem (ELV) | 5.6 | $25M | 48k | 512.97 | |
| Merck & Co (MRK) | 5.1 | $22M | 199k | 110.95 | |
| Medtronic SHS (MDT) | 4.9 | $22M | 277k | 77.72 | |
| Zimmer Holdings (ZBH) | 4.5 | $20M | 154k | 127.50 | |
| Biogen Idec (BIIB) | 4.4 | $19M | 70k | 276.92 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 4.0 | $18M | 75k | 235.48 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $16M | 155k | 103.49 | |
| Centene Corporation (CNC) | 3.5 | $15M | 185k | 82.01 | |
| Seagen | 3.1 | $14M | 106k | 128.51 | |
| Boston Scientific Corporation (BSX) | 3.1 | $14M | 295k | 46.27 | |
| Bruker Corporation (BRKR) | 3.0 | $13M | 192k | 68.35 | |
| Edwards Lifesciences (EW) | 3.0 | $13M | 174k | 74.61 | |
| Qiagen Nv Shs New | 2.7 | $12M | 234k | 49.87 | |
| Baxter International (BAX) | 2.6 | $11M | 221k | 50.97 | |
| Illumina (ILMN) | 2.2 | $9.6M | 48k | 202.20 | |
| Tenet Healthcare Corp Com New (THC) | 2.2 | $9.6M | 196k | 48.79 | |
| Cigna Corp (CI) | 1.7 | $7.4M | 22k | 331.34 | |
| NuVasive | 1.6 | $7.2M | 174k | 41.24 | |
| Bio Rad Labs Cl A (BIO) | 1.5 | $6.7M | 16k | 420.49 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $5.3M | 141k | 37.77 | |
| CVS Caremark Corporation (CVS) | 0.9 | $4.0M | 43k | 93.19 | |
| Biontech Se Sponsored Ads (BNTX) | 0.8 | $3.6M | 24k | 150.22 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $3.3M | 87k | 38.17 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $3.0M | 186k | 15.92 | |
| Catalent (CTLT) | 0.6 | $2.5M | 55k | 45.01 | |
| Vir Biotechnology (VIR) | 0.5 | $2.3M | 90k | 25.31 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $2.1M | 46k | 46.33 |
